Earkart Limited
Earkart Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q2 FY26 call signalled
3 of 4 strong
The short version
Earkart aims to reach approximately ₹300 crore turnover in 5 years (by 2030). Earkart aims to become a ₹300 crore company within 5 years (by 2030).
From Earkart Limited's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Earkart aims to reach approximately ₹300 crore turnover in 5 years (by 2030).
- Targeting 500 to 550 clinic installations by FY 2027, with installation cost per device around ₹2.7 lakh per clinic.
- Expecting a compound annual growth rate (CAGR) of about 25% this year and aiming to sustain similar growth next year.
- Private sector revenue share expected to grow to about 70% within 5 years, with government orders range-bound around 20-30%.
- Revenue from clinics expected to rise significantly, e.g., from 110 clinics generating roughly ₹10-11 crore at full capacity.
- Focus on expanding geographical presence across India, moving from North to West, South, and eventually East.
2 more points from Earkart Limited's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Earkart Limited said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has planned installation of around 500 to 550 clinics by the end of FY 2027.
- The installation cost per device is approximately ₹2.7 lakh per clinic.
- Recent IPO proceeds include unutilized funds sufficient to cover the capex for clinic installations.
- By the time 350 installations are achieved, the business model is expected to become self-sustaining.
- Expansion involves hiring more employees and setting up new infrastructure to support growth.
- Investments are also being made in improving the OMNI Audiometer for better efficiency and availability.
- Strategic expansion planned geographically from North India towards West, South, and eventually East India.
2 more points from Earkart Limited's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Earkart Limited said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Earkart has already secured government orders worth approximately ₹9 crores in the current fiscal year (Page 8, 7th excerpt).
- Four government tenders, usually opening before September, were deferred but two have already opened, with 2-3 more expected to open in the second half of the fiscal year (Page 8).
- The second half of the year is expected to see a significant scale-up in order inflows due to these tender openings (Page 8).
- Private sector orders have grown by over 25% compared to last year, supporting overall revenue despite deferred government orders (Page 8).
2 more points from Earkart Limited's call on order book
Pro opens every point from 15K+ earnings calls
Continue your research
Others in Healthcare Equipment & Supplies this season
- Aprameya Enginee (Q2 FY26)
H1FY26 Revenue from Operations: Rs 421.4 Mn, up 343% YoY from Rs 92.7 Mn in H1FY25. Key investor presentation takeaways from Aprameya Engineering Ltd's Q2 FY26
- Vaidya Sane (Q2 FY26)
Ongoing construction and CAPEX of about INR 25-30 crores for capacity expansion at Khopoli and Nagpur hospitals. Key concall takeaways from Vaidya Sane's Q2…
- QMS Medical Allied Services Ltd (Q2 FY26)
The only related transaction noted is the recent acquisition of Saarathi increasing stake from 51% to 76%, but no fundraising details were shared with respect…
- Poly Medicure Ltd (Q2 FY26)
1,090 crores, representing over 25% growth compared to H1 (Rs. Key concall takeaways from Poly Medicure's Q2 FY26 earnings call — and how it ranks against…
Arthneeti Pro · Annual
Earkart Limited and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Earkart Limited Q2 FY26 results?
Earkart aims to reach approximately ₹300 crore turnover in 5 years (by 2030). Earkart aims to become a ₹300 crore company within 5 years (by 2030).
What is Earkart Limited share price analysis?
Earkart Limited currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 39.0 with a market cap of ₹192 Cr. Investors should review the full earnings analysis for detailed insights.
Is Earkart Limited planning capital expenditure?
The company has planned installation of around 500 to 550 clinics by the end of FY 2027.
Keep Earkart Limited on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.